Ginsenoside Rg1 ameliorated the behavioral deficits of PD mice model.
Dopaminergic cell loss reduced with ginsenoside Rg1 treatment in vivo.
Cell viability was increased by ginsenoside Rg1 pretreatment.
Ginsenoside Rg1 pretreatment decreased cell apoptosis.
The neuroprotective effects of ginsenoside Rg1 are exerted through the Wnt/β-catenin signaling pathway.